Haemonetics acquires Vivasure Medical for EUR 100M

Haemonetics (HAE) announced the acquisition of Vivasure Medical. The acquisition includes an upfront cash payment of EUR 100M, or approximately EUR 52M net of the value of certain previous investments and other loans made by Haemonetics to Vivasure as well as other customary closing adjustments, and up to an additional EUR 85M in contingent consideration based on sales growth and the achievement of certain other milestones, also subject to adjustment based on the value of certain prior investments and loan amounts. Haemonetics financed this transaction through available cash on hand.